NCT04886414

Brief Summary

This study aims to enroll patients with acute infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) who do not meet criteria for hospital admission according to protocols developed by the Honduras Ministry of Health (MOH). Patients who are triaged to home must also be over the age of 60 years or have one high risk comorbidity and be over 45 years in order to meet inclusion criteria. These patients will be randomly assigned to one of four home-based care strategies, which may or may not include regular blood oxygenation monitoring and provision of alcohol-based hand-rub. Patients will be followed until resolution of their acute illness, and data will be collected on feasibility, impact and acceptance of the intervention. Some patients will be followed for up to one year to monitor for post-Coronavirus Disease 2019 (COVID-19) symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,821

participants targeted

Target at P75+ for not_applicable covid19

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 14, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

March 31, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

10 months

First QC Date

May 10, 2021

Last Update Submit

May 9, 2025

Conditions

Keywords

Home-Based CareWater, Sanitation and HygieneAlcohol-Based Hand SanitizerTriagePost-Covid SyndromeCommunity Health Workers

Outcome Measures

Primary Outcomes (4)

  • Disposition after referral

    Disposition (home, admission, other) for those referred to a higher level of care

    28 days

  • Duration of hospitalization

    Duration of hospitalization (days) for those who are admitted

    90 days

  • Duration of ICU and/or ventilator requirement

    Duration of ICU and/or ventilator requirement (days) for those requiring critical care

    90 days

  • Mortality

    Death prior to discharge from acute COVID-19 monitoring

    90 days

Other Outcomes (11)

  • Proportion that receive the prescribed follow-up plan

    28 days

  • Proportion with complete pulse oximetry data

    28 days

  • Loss to follow-up

    90 days

  • +8 more other outcomes

Study Arms (4)

Phone-based monitoring without blood oxygenation monitoring with ABHS

EXPERIMENTAL

Study staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features will be documented on a phone-based patient monitoring form. Subjects will received a home-based care kit that contains alcohol-based hand sanitizer (ABHS).

Other: Phone-based monitoringOther: Alcohol-based hand sanitizer

Phone-based monitoring without blood oxygenation monitoring without ABHS

EXPERIMENTAL

Study staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features will be documented on a phone-based patient monitoring form. Subjects will received a home-based care kit that does not contain alcohol-based hand sanitizer.

Other: Phone-based monitoring

Phone-based monitoring with blood oxygenation monitoring with ABHS

EXPERIMENTAL

Study staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features and oxygen saturation levels will be documented on a phone-based patient monitoring form. Oxygen saturation level will be assessed four times per day (morning, midday, evening, plus during the phone-based assessment) by the patient and/or family member and the lowest stable (i.e. without substantial fluctuations) level recorded during a monitoring period of one minute will be recorded and registered. Patient's will be provided monitoring sheets to record the times and dates of the oxygen saturation levels. Subjects will received a home-based care kit that contains alcohol-based hand sanitizer.

Other: Phone-based monitoringOther: Oxygen saturation monitoringOther: Alcohol-based hand sanitizer

Phone-based monitoring with blood oxygenation monitoring without ABHS

EXPERIMENTAL

Study staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features and oxygen saturation levels will be documented on a phone-based patient monitoring form. Oxygen saturation level will be assessed four times per day (morning, midday, evening, plus during the phone-based assessment) by the patient and/or family member and the lowest stable (i.e. without substantial fluctuations) level recorded during a monitoring period of one minute will be recorded and registered. Patient's will be provided monitoring sheets to record the times and dates of the oxygen saturation levels. Subjects will received a home-based care kit that does not contain alcohol-based hand sanitizer.

Other: Phone-based monitoringOther: Oxygen saturation monitoring

Interventions

Study staff will perform daily phone-based assessments using standardized electronic study tools (tablets). Clinical features will be documented on a phone-based patient monitoring form.

Phone-based monitoring with blood oxygenation monitoring with ABHSPhone-based monitoring with blood oxygenation monitoring without ABHSPhone-based monitoring without blood oxygenation monitoring with ABHSPhone-based monitoring without blood oxygenation monitoring without ABHS

Oxygen saturation will be monitored and recorded at regular intervals.

Phone-based monitoring with blood oxygenation monitoring with ABHSPhone-based monitoring with blood oxygenation monitoring without ABHS

Alcohol-based hand sanitizer will be distributed to subjects.

Phone-based monitoring with blood oxygenation monitoring with ABHSPhone-based monitoring without blood oxygenation monitoring with ABHS

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients presenting with acute infection with SARS-CoV-2.
  • Patients test positive for SARS-CoV-2 with rapid antigen test.
  • Patients triaged to HBC by SESAL clinicians according to existing SESAL policies and protocols.
  • Greater than 60 years of age OR greater than 45 years AND at least one comorbidity which increases risk for poor outcomes due to COVID-19.
  • Live or work in the city where the study is being implemented
  • Agrees to participate and signs informed consent

You may not qualify if:

  • Less than 45 years of age
  • Incapable of giving assent to participate due to medical condition at the time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

COVID-19 Triage Centers

Tegucigalpa, Francisco Morazán Department, Honduras

Location

Related Publications (1)

  • Roberts KW, Alvarez B, de St Aubin M, Diaz O, Garnier S, Schnorr CD, Cruz S, Pavon L, Ochoa A, See R, Medice S, Santos HM, Ochoa J, Solis S, Dumas D, Baldwin M, Martinez A, Hakim A, Nilles E. Impact of self-administered pulse oximetry among non-hospitalized patients at risk of severe COVID-19 in Honduras: A pragmatic, cluster-randomized trial with temporal clustering. PLOS Glob Public Health. 2025 Nov 7;5(11):e0004618. doi: 10.1371/journal.pgph.0004618. eCollection 2025.

MeSH Terms

Conditions

COVID-19

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Model Details: Participants will be block randomized to one of four possible home-based care strategies.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 10, 2021

First Posted

May 14, 2021

Study Start

March 31, 2022

Primary Completion

January 15, 2023

Study Completion

February 28, 2023

Last Updated

May 14, 2025

Record last verified: 2025-05

Locations